Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors.

Autor: Gene-Olaciregui N; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Perez-Somarriba M; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Santa-María V; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Cruz O; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Gómez-González S; Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Castañeda A; Pediatric Solid Tumor Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Suñol M; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain., Rovira C; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain., Muchart J; Department of Radiology, Hospital Sant Joan de Déu, Barcelona, Spain., Hinojosa J; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., La Madrid AM; Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain., Lavarino C; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
Jazyk: angličtina
Zdroj: JCO precision oncology [JCO Precis Oncol] 2023 Mar; Vol. 7, pp. e2200547.
DOI: 10.1200/PO.22.00547
Databáze: MEDLINE